WHITEHAWK THERAPEUTICS, INC. Capital Expenditures Incurred but Not yet Paid
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-03-12
- WHITEHAWK THERAPEUTICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $0.00.
- WHITEHAWK THERAPEUTICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. capital expenditures incurred but not yet paid for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- WHITEHAWK THERAPEUTICS, INC. capital expenditures incurred but not yet paid for fiscal 2024 was $1.15M, a 101.93% increase from fiscal 2023.
- WHITEHAWK THERAPEUTICS, INC. capital expenditures incurred but not yet paid for fiscal 2023 was $571.00K, a 613.75% increase from fiscal 2022.
- WHITEHAWK THERAPEUTICS, INC. capital expenditures incurred but not yet paid for fiscal 2022 was $80.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $0.00 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | $725.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $725.00K derived: sum of 3 quarters · filed 2026-03-12 | $562.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $725.00K derived: sum of 2 quarters · filed 2026-03-12 | $562.00K derived: sum of 3 quarters · filed 2026-03-12 | $613.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | $725.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $562.00K derived: sum of 2 quarters · filed 2026-03-12 | $613.00K derived: sum of 3 quarters · filed 2026-03-12 | $1.15M 10-K · filed 2026-03-12 |
| 2024-09-30 | -$163.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$112.00K derived: sum of 2 quarters · filed 2025-11-06 | $428.00K 10-Q · filed 2025-11-06 | $877.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $591.00K 10-Q · filed 2025-08-07 | $1.04M derived: sum of 3 quarters · filed 2025-08-07 | $643.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $540.00K 10-Q · filed 2025-05-08 | $989.00K derived: sum of 2 quarters · filed 2025-05-08 | $592.00K derived: sum of 3 quarters · filed 2025-05-08 | $724.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $449.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $52.00K derived: sum of 2 quarters · filed 2025-03-28 | $184.00K derived: sum of 3 quarters · filed 2025-03-28 | $571.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | -$397.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$265.00K derived: sum of 2 quarters · filed 2024-11-06 | $122.00K 10-Q · filed 2024-11-06 | $142.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $132.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $519.00K 10-Q · filed 2024-08-07 | $539.00K derived: sum of 3 quarters · filed 2024-08-07 | $548.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $387.00K 10-Q · filed 2024-05-08 | $407.00K derived: sum of 2 quarters · filed 2024-05-08 | $416.00K derived: sum of 3 quarters · filed 2024-05-08 | $440.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $29.00K derived: sum of 2 quarters · filed 2024-03-13 | $53.00K derived: sum of 3 quarters · filed 2024-03-13 | $80.00K 10-K · filed 2024-03-13 |
| 2022-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $33.00K derived: sum of 2 quarters · filed 2023-11-08 | $60.00K 10-Q · filed 2023-11-08 | $60.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $51.00K 10-Q · filed 2023-08-09 | $51.00K derived: sum of 3 quarters · filed 2023-08-09 | $51.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $27.00K 10-Q · filed 2023-05-10 | $27.00K derived: sum of 2 quarters · filed 2023-05-10 | $27.00K derived: sum of 3 quarters · filed 2023-05-10 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $0.00 derived: sum of 2 quarters · filed 2023-03-29 | $0.00 10-K · filed 2023-03-29 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |